About Labopharm
Labopharm is a Healthcare company based in Quebec City (Canada) founded in 1990, and was acquired by Paladin Labs in August 2011. Performance of existing drugs is optimized via controlled-release technologies. Its focus areas include Diversified Pharmaceuticals.
Company details
Labopharm is a specialty pharmaceutical company focused on optimizing the performance of existing drugs by incorporating its advanced controlled-release technologies. The Companys lead product, a once-daily formulation of the analgesic tramadol, is being commercialized internationally and is focused on pursuing additional launches in markets around the world. Its second product, OLEPTRO, a once-daily formulation of trazodone (a serotonin antagonist reuptake inhibitor) for the treatment of major depressive disorder (MDD) has received regulatory approval from the United States Food and Drug Administration (FDA) and is in the process of finalizing the commercialization plan for its product. It is also developing a series of abuse- and misuse-deterrent products based on its Contramid-based technology platform. In addition, it has other products in development utilizing its Contramid or its polymeric nano-delivery system (PNDS) technologies
- Headquarters Quebec City, Canada
- Stage Acquired
- SectorsHealthcare
- Website labopharm.com
- Social LinkedIn
- Acquired by Paladin Labs (Aug 2011)
- Latest Funding Round$23.53M (USD), Debt – Conventional
Nov 2009
- Investors
- Acquired byPaladin Labs
(Aug 2011)
Funding Insights of Labopharm
- Total Rounds 1
- Last Round Debt – Conventional — $23.53M
- First Round $23.53M
(Nov 2009)
All 1 funding rounds of Labopharm with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2009 | $23.53M | Debt – Conventional | – | – | – |
1 investors in total: 1 institutional.
Investors in Labopharm
Labopharm has secured backing from 1 investor. Prominent investors backing the company include Paladin Labs.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Innovative pharmaceutical products are acquired and in-licensed by Paladin Labs. | 1983 | paladin-labs.com | Montreal, Canada |
Investor details for Labopharm
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Labopharm
3 dated milestones of Labopharm across 21 years, from founding to its latest funding, stage changes and deals.
- Founded Labopharm is founded.
- Funding First funding round of $23.5M.
- Exit Acquired by Paladin Labs.
Web traffic of Labopharm
Websites that share an audience with Labopharm (labopharm.com).
Websites whose visitors overlap most with Labopharm. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
capsulution.com | capsulution.com | 100% | #3,311,802 | – | |
bionanomatrix.com | bionanomatrix.com | 100% | – | ||
| hybridplastics.com | 100% | 1.8K | #6,871,765 | View details | |
| fivestartech.com | 100% | 3.5K | #4,842,951 | View details | |
| firstnano.com | 100% | View details | |||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 14 similar websites and full traffic analytics for Labopharm
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 14 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Labopharm
Labopharm was founded in 1990 and raised its 1st funding round 19 years after it was founded.
Labopharm is headquartered in Quebec City, Canada. It is registered at Quebec City, Quebec, Canada.
Labopharm is a specialty pharmaceutical company focused on optimizing the performance of existing drugs by incorporating its advanced controlled-release technologies. The Companys lead product, a once-daily formulation of the analgesic tramadol, is being commercialized internationally and is focused on pursuing additional launches in markets around the world. Its second product, OLEPTRO, a once-daily formulation of trazodone (a serotonin antagonist reuptake inhibitor) for the treatment of major depressive disorder (MDD) has received regulatory approval from the United States Food and Drug Administration (FDA) and is in the process of finalizing the commercialization plan for its product. It is also developing a series of abuse- and misuse-deterrent products based on its Contramid-based technology platform. In addition, it has other products in development utilizing its Contramid or its polymeric nano-delivery system (PNDS) technologies.
Labopharm has 1 investor. Key investors include Paladin Labs.
Yes. Labopharm was acquired by Paladin Labs in August 2011.